Nedlands-based pharmaceutical company PharmAust Ltd will take a 39.5 per cent stake in NASDAQ-listed US-based Commonwealth Biotechnologies Inc in exchange for its its discovery chemistry subsidiary Mimotopes Pty Ltd.

Nedlands-based pharmaceutical company PharmAust Ltd will take a 39.5 per cent stake in NASDAQ-listed US-based Commonwealth Biotechnologies Inc in exchange for its its discovery chemistry subsidiary Mimotopes Pty Ltd.